"As the leading company in Austria, we must leverage our influence to ensure that Austria can facilitate and embrace innovation as the healthcare environment here, as…
In Conversation
"For the first time, after many years, we have a government commitment to increase the budget allocated to research by 20 percent"
"We are extremely active within industry associations as we do not want to wait for change, but be the ones that help shape the Austrian healthcare…
"[Aspen] has the strong wish to work closely with the government, especially in order to help augment its efficiency in the pharmaceutical field."
"Through Pascal Soriot’s global leadership, AstraZeneca has a robust and exciting global pipeline that we can leverage at the local level."
"As the market is experiencing frequent regulatory changes, the requirements have transformed, necessitating an alteration in the way we approach the market."
"In 2016, Brazil’s overall inflation rate reached 19.8 percent, but the quality of services accessible to our patients is far from increasing at the same pace…
"Last year, our plant was recognized as Baxter’s number one plant globally in terms of quality. We are proud of the level of quality that can…
"Our contribution to the country’s healthcare system has been very good, especially in remote zones. In addition, RTS is involved permanently in the publication of financial…
"We at ACRO have always focused on advocating for our members, as well as for our whole sector; our interest is an environment that is positive…
"What makes our ability to shorten the quality control process so important is that you do not save costs only by ameliorating your operative capacity. The…
"Ipsen Canada has had a great start. We are somewhat of a poster child for the Ontario government now when it comes to attracting more foreign…
